FSD Pharma (HUGE) Stock Price, News & Analysis

Company Overview

FSD Pharma Inc. operates as a cannabis company in Canada. It is involved in hydroponic indoor cannabis production and processing activities. The company, through its subsidiary, FV Pharma Inc., holds license to produce marijuana under the Access to Cannabis for Medical Purposes Regulations. It has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products developed by SciCann Therapeutics Inc. The company was formerly known as Century Financial Capital Group Inc. and changed its name to FSD Pharma Inc. in May 2018. FSD Pharma Inc. was incorporated in 1994 and is headquartered in Cobourg, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 4,870 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HUGE Stock Analysis - Frequently Asked Questions

How do I buy shares of FSD Pharma?

Shares of HUGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of FSD Pharma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that FSD Pharma investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Canopy Growth (CGC), Aphria (APHA), Kirkland Lake Gold (KL), Aurora Cannabis (ACB) and Bombardier, Inc. Class B (BBD.B).

Industry, Sector and Symbol

• Stock Exchange: CNSX
• Sector: Computer and Technology
• Industry: Software - Application
• Sub-Industry: N/A
• Current Symbol: CNSX:HUGE
• CUSIP: N/A
• CIK: N/A
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A